Short answer
ARDELYX, INC. (ARDX) filed an 8-K current report with the SEC on November 3, 2026 reporting Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), Item EX-99.1 (Exhibit EX-99.1), Item EX-99.2 (Exhibit EX-99.2). Ardelyx announced financial results for the quarter ended September 30, 2026.
ARDELYX, INC. 8-K event analysis
AI summary of each reported item and its exhibits
Item 2.02 · Results of Operations and Financial Condition
- Ardelyx announced financial results for the quarter ended September 30, 2026
- Full quarterly results and management commentary are provided in Exhibit 99.1
- Results announcement gives investors updated visibility into quarterly operating performance and financial condition
Item 7.01 · Regulation FD Disclosure
- Earnings presentation for quarter ended September 30, 2026 furnished as Exhibit 99.2
- November 3, 2026 conference call covering quarterly financial results
- Investor focus: presentation may provide management commentary and operating updates beyond reported figures
Item EX-99.1 · Exhibit EX-99.1
- Q3 product revenue $125.5M, up 19%, led by IBSRELA revenue $96.3M, up 23%
- XPHOZAH revenue $29.2M, up 7%, indicating slower growth than IBSRELA
- Q3 net loss narrowed to $0.7M from $1.0M, while nine-month net loss reached $55.1M
- Cash, equivalents and investments rose to $285.3M, supporting commercial expansion and ACCEL trial execution
- ACCEL enrollment completed ahead of schedule, with topline data expected in the second half of 2027
Item EX-99.2 · Exhibit EX-99.2
- Q3 product revenue $125.5M, up 19% YoY, with IBSRELA growth offsetting slower XPHOZAH expansion
- IBSRELA revenue $96.3M, up 23% YoY, supporting long-term $1B annual revenue ambition
- XPHOZAH revenue $29.2M, up 7% YoY, indicating continued momentum in dialysis hyperphosphatemia treatment
- Net loss narrowed to $0.7M, while operating expenses rose 17% to $119.1M
- FY2026 guidance reaffirmed: IBSRELA $350-$370M, XPHOZAH $110-$120M, operating expenses below $500M
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other ARDELYX, INC. 8-K filings
Get the next ARDX 8-K as it lands
Follow ARDX for push alerts, or ask the research agent what this filing means.